aurantiamide has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, Q; He, Z; Pei, H; Shen, H; Wang, G; Zhai, L | 1 |
| Guan, Q; Pei, H; Shen, H; Wang, G; Zhai, L | 1 |
2 other study(ies) available for aurantiamide and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Aurantiamide promotes M2 polarization of microglial cells to improve the cognitive ability of mice with Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cognition; Dipeptides; Mice; Microglia | 2023 |
Aurantiamide suppresses the activation of NLRP3 inflammasome to improve the cognitive function and central inflammation in mice with Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cognition; Dipeptides; Inflammasomes; Inflammation; Mice; Mice, Inbred C57BL; Microglia; NLR Family, Pyrin Domain-Containing 3 Protein | 2023 |